Latest Breaking News On - Leahb rethy - Page 1 : vimarsana.com

 E-Mail DALLAS, April 5, 2021 When people with human immunodeficiency virus (HIV) develop high blood pressure, the type of medication chosen for their initial treatment may influence their risk of heart disease, stroke and heart failure, according to new research published today in Hypertension, an American Heart Association journal. With current anti-retroviral medications, people with HIV are able to live longer. However, people with HIV receiving anti-retroviral therapy (ART) are more likely to develop high blood pressure (hypertension) and hypertension-related heart problems than people who do not have the virus. The current study is the first to examine how the choice of blood pressure medications influences the long-term risk of heart disease, stroke and heart failure in this population that has a higher risk of CVD.

University of pennsylvaniaUnited statesSanjivj shahMatthewj feinsteinRaymondr townsendAdamp bressLeahb rethyJordanab cohenVeterans health administrationAmerican heart associationNational institutes of healthPerelman school of medicineSarnoff cardiovascular foundationPerelman schoolNational institutesCardiovascular disease